Physician profile
James Lilja
NPI 1225081441
$73,353.55
in general payments reported to CMS, 2019-2025
47 companies · $7,101 in 2025
The $7,101 reported for 2025 was more than what 89% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $4,108 · 2021: $12K · 2022: $17K · 2023: $9,153 · 2024: $2,602 · 2025: $7,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $3,503 · Education: $2,100 · Travel and Lodging: $1,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,195.00 |
| Food and Beverage | $3,503.31 |
| Education | $2,099.99 |
| Travel and Lodging | $1,057.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $27,364.61 | 2019-2025 | Spy-Phi System |
| Ethicon INC. | $18,952.50 | 2019-2022 | |
| Roche Molecular Systems, INC. | $10,000.00 | 2020-2021 | |
| Conmed Corporation | $5,443.01 | 2019-2022 | |
| Abbvie INC. | $2,201.30 | 2019-2025 | |
| Intuitive Surgical, INC. | $2,179.41 | 2024-2025 | |
| Histosonics, INC. | $1,057.41 | 2025 | |
| Applied Medical Resources Corporation | $875.70 | 2019-2021 | |
| Dilon Technologies, INC. | $733.59 | 2023-2025 | Hemoblast Bellows |
| Astrazeneca Pharmaceuticals LP | $413.82 | 2019-2025 | Lynparza |
| Hologic INC | $400.00 | 2024 | Coolseal Generator |
| Hologic Sales and Service, LLC | $400.00 | 2024 | Coolseal Generator |
| Sanara Medtech INC. | $340.87 | 2024-2025 | Celleraterx, Celleraterx, Biasurge |
| Teleflex LLC | $310.19 | 2021-2024 | Titan Sgs, Quikclot, Titan Sgs Standard Gastric Stapler |
| Myriad Genetic Laboratories, INC. | $293.37 | 2022-2024 | Precisetumor |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $243.54 | 2022-2025 | Harmonic, Surgiflo Hemostatic Matrix, Proximate |
| Astellas Pharma US INC | $211.03 | 2024-2025 | Veozah |
| Medtronic, INC. | $184.99 | 2021-2024 | Interstim, Ligasure |
| Coloplast Corp | $172.81 | 2021-2025 | Altis, Saffron |
| Zoll Medical Corporation | $166.56 | 2019 | |
| Smith+Nephew, INC. | $114.44 | 2025 | Stravix |
| Eisai INC. | $111.05 | 2024-2025 | |
| Dysis Medical, INC. | $106.37 | 2020-2022 | |
| Davol INC. | $97.12 | 2019-2022 | |
| Biotissue Holdings INC. | $94.08 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $92.05 | 2019-2024 | Lynparza |
| Baxter Healthcare | $84.16 | 2020-2024 | Perclot, Adept |
| Seagen INC. | $71.36 | 2022-2023 | Tivdak |
| Covidien LP | $60.91 | 2019-2020 | |
| Myovant Sciences INC. | $58.92 | 2021-2022 | |
| Clovis Oncology, INC. | $58.89 | 2021-2022 | |
| Bluewind Medical | $56.61 | 2025 | Revi |
| Minerva Surgical, INC | $52.51 | 2023-2025 | |
| Integra Lifesciences Corporation | $47.48 | 2020-2025 | Codman Hakim, Codman Certas, Cusa Clarity |
| Becton, Dickinson and Company | $42.26 | 2024 | Arista Ah Flexitip |
| Pfizer INC. | $39.47 | 2022-2025 | |
| Activ Surgical, INC. | $31.92 | 2022 | |
| Verastem, INC. | $25.81 | 2025 | Avmapki Fakzynja Co-Pack |
| Baudax Bio INC. | $23.42 | 2020 | |
| Tactile Systems Technology INC | $23.07 | 2025 | Flexitouch Plus, Nimbl |
| Meditrina | $19.44 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $18.77 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $17.72 | 2022 | |
| Heron Therapeutics, INC. | $17.04 | 2023 | Zynrelef |
| Trisalus Life Sciences, INC. | $15.90 | 2025 | Trinav Infusion System |
| Olympus America INC. | $14.97 | 2020 | |
| Roche Diagnostics Corporation | $13.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lilja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.